Capricor Therapeutics

Capricor Therapeutics is a clinical-stage biotechnology company focused on developing transformative cell and exosome-based therapies for rare diseases. The firm's lead product candidate, Deramiocel, is an allogeneic cardiac-derived cell therapy currently in Phase 3 clinical trials for the treatment of Duchenne muscular dystrophy. Additionally, the company leverages its proprietary StealthX platform to engineer exosomes for vaccines and targeted delivery of nucleic acids and proteins to treat a broad range of medical conditions.

Cómo comprar Capricor Therapeutics en Grow →